Studied for decades in viral hepatitis and oncology (Goldstein et al., Expert Opinion on Biological Therapy, 2009), T1 is now being examined for its capacity to reduce the autoimmune T-cell response in Hashimoto's with preliminary data suggesting potential reduction in TPO antibody levels
But the plunger cannot reach all the way to the very tip of the needle
Randomised clinical trial: The efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease
Despite their broad spectrum of antioxidant, anti-inflammatory, neuroprotective, antimicrobial, anti-diabetic, and anti-cancer activities, the therapeutic application of polyphenols is significantly hindered by their inherently poor bioavailability
* Kisspeptin-10 Structure Source: PubChem
[59] These findings were further supported by a 2025 review of interventions for adolescents, which concluded that medications and cognitive-behavioral treatments (CBT) provide complementary benefits
